CemarkingDubai Blog

Medibio Receives CE Certification

Medibio Limited (MEB or the Company) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, is pleased to confirm it has received CE (Conformité Européenne) Marking certification for its first release technology product and platform.

Demonstrating that the product complies with European health and safety standards, the CE Marking was granted on 2 May 2018 (GMT) by DQS Med for Medibio’s product and platform.

The successful introduction of rest of world applications in key countries will provide Medibio with the ability to further commercialize its technology and platform in alignment with our strategic plans for additional product releases.

Supported by its technological and scientific platform, Medibio’s product permits clinicians and individuals to evaluate stress-level phenotypes, combined with dimensional circadian heart-sleep biometrics and physiological biometrics. With the support of Medibio’s app-based and web-based scientific platforms, this comprehensive system will permit for the non-invasive, comprehensive evaluation and monitoring of mental health.

“Acquiring CE Marking represents the successful completion of a lengthy and thorough estimation procedure, and marks an important threshold for the company. We are pleased to have delivered against this key milestone. Alongside the recent declaration of our corporate mental health product, this accomplishment provides further validation of the product offering and technology,” said CEO and Managing Director, Jack Cosentino. “We are eager to progress to a new phase, and committed across the organization to deliver exceptional product quality and operational excellence as we work towards transforming mental health care delivery.”